Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib [PDF]
Yoshihiro Fujimura +7 more
openalex +1 more source
Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin [PDF]
Jan J. Sixma +3 more
openalex +1 more source
Comparison of 2 ways of performing ristocetin-induced platelet agglutination mixing study for diagnosis of type 2B von Willebrand disease. Response to the publication of Soleimani et al [PDF]
Emmanuel J. Favaloro, Maha Othman
openalex +1 more source
Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides [PDF]
Batta, Gyula +12 more
core +1 more source
Inhibitory mechanism of ristocetin-induced platelet aggregation by IgG1(.LAMBDA.) M component.
Haruo Nakamura
openalex +2 more sources
Antibodies Against Platelet Membrane Glycoproteins: Effect On Ristocetin-Induced Platelet Aggregation [PDF]
Elizabeth F. Ali‐Briggs +2 more
openalex +1 more source
Identification of functional domains on von Willebrand factor by binding of tryptic fragments to collagen and to platelets in the presence of ristocetin [PDF]
WP Houdijk, ME Schiphorst, JJ Sixma
openalex +1 more source
Type 2M von Willebrand Disease: F606I and I662F Mutations in the Glycoprotein Ib Binding Domain Selectively Impair Ristocetin- but not Botrocetin-Mediated Binding of von Willebrand Factor to Platelets [PDF]
Cheryl A. Hillery +8 more
openalex +1 more source
Evaluation of a Rapid Automated Assay for Analysis of von Willebrand Ristocetin Cofactor Activity [PDF]
Karin Strandberg +4 more
openalex +1 more source

